CD28 and neoplasm: T cell identification and action versus tumor antigens necessitate dual T cell receptors to bind with antigen peptides delivered inside the environment of major complexes of histocompatibility, as well as costimulatory receptor activation of CD28 on T cells and CD (80/86) on those cell that have antigen-containing cells, or cancer cell (tumor) [51].